Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
85.9M
-
Shares change
-
+10.2M
-
Total reported value, excl. options
-
$2.95B
-
Value change
-
+$357M
-
Put/Call ratio
-
1.14
-
Number of buys
-
127
-
Number of sells
-
-61
-
Price
-
$34.31
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2020
219 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q2 2020.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.9M shares
of 114M outstanding shares and own 75.17% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (12.6M shares), FMR LLC (6.34M shares), BlackRock Inc. (6.1M shares), VANGUARD GROUP INC (5.1M shares), JANUS HENDERSON GROUP PLC (3.66M shares), FARALLON CAPITAL MANAGEMENT LLC (3.5M shares), Johnson & Johnson Innovation - JJDC, Inc. (3.38M shares), CITADEL ADVISORS LLC (3.28M shares), STATE STREET CORP (3.1M shares), and Casdin Capital, LLC (3.05M shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.